• Lehigh Team Uses Digital Twin of Gut-Brain Axis to Advance Neurostimulation Therapies

    Bio-IT World | AI is reshaping pharmaceutical manufacturing. We see it being used to automate tasks, uncover insights, and optimize quality. By analyzing complex, rich datasets, AI can predict deviations, fine-tune processes, and accelerate routine tasks and documentation, leading to faster production and higher-quality outcomes. Good Manufacturing Practice environments are precise, traceable, and controlled. Yet as operations scale and complexity grow, maintaining GMP standards is increasingly difficult. This is where AI excels.

    Sep 15, 2026

  • What It Takes to Make Generative AI Fit for GMP

    Bio-IT World | AI is reshaping pharmaceutical manufacturing. We see it being used to automate tasks, uncover insights, and optimize quality. By analyzing complex, rich datasets, AI can predict deviations, fine-tune processes, and accelerate routine tasks and documentation, leading to faster production and higher-quality outcomes. Good Manufacturing Practice environments are precise, traceable, and controlled. Yet as operations scale and complexity grow, maintaining GMP standards is increasingly difficult. This is where AI excels.

    Sep 11, 2026

  • Ultima, NVIDIA, Google Partner on Pangenome-Aware Whole Genome Sequencing

    Bio-IT World | Ultima Genomics and NVIDIA are collaborating to enable pangenome-aware whole genome sequencing (WGS) analysis, combining Ultima’s high-output, cost-efficient sequencing platform with accelerated GPU-enhanced computational approaches from NVIDIA and Google’s open source DeepVariant for pangenome graph alignment and variant calling. The collaboration aims to make pangenome-aware WGS variant calling practical.

    Sep 9, 2026

  • Clearing the Bench-To-Bedside Hurdle: Why Translational Medicine Needs to Start Earlier

    Bio-IT World | There’s an enormous graveyard for medical innovations that showed tremendous promise in the lab yet stalled out in early clinical trials and never reached patients at scale. We've largely come to accept this high failure rate as an inevitable reality of translational medicine. But over the past 17 years developing an implantable ultrasound platform for blood-brain barrier modulation, I've come to a different conclusion: we're asking translational medicine to solve problems that should have been addressed much earlier in development.

    Sep 4, 2026

  • NVIDIA Acquires Hugging Face for $12.93 Billion

    Bio-IT World This morning NVIDIA announced its agreement to acquire Hugging Face for $12.93 billion. The two groups plan to scale Hugging Face’s platform, strengthen its infrastructure and expand access to AI for developers and institutions worldwide.

    Sep 3, 2026

  • Deep-Learning Tool Uses Long-Read Sequencing to Detect Cancer Mutations

    Bio-IT World | Analyzing genetic changes in cancer cells can provide insight into how tumors develop and inform precision oncology. However, identifying cancer-related mutations can be challenging, particularly when they occur at low frequencies or in complex regions of the genome. Researchers at The University of Hong Kong have developed ClairS, a tool designed to detect small cancer-related genetic mutations from long-read sequencing data.

    Sep 2, 2026

  • Trends from the Trenches: Rethinking Computational Workflows for Modern Genomics

    Bio-IT World | Modern genomics and precision medicine are generating data at a scale that is challenging traditional bioinformatics workflows. As researchers increasingly combine genomic data with phenotype, transcriptomics, proteomics, and imaging, they face growing demands for reproducible pipelines, standardized methods, and collaboration across laboratories, hospitals, and biobanks. In the latest episode of Trends from the Trenches, Ben Busby, global alliance manager for omics at NVIDIA, argues that addressing those challenges requires a shift in how scientists approach computational research.

    Sep 1, 2026

  • Trends from the Trenches: Rethinking Computational Workflows for Modern Genomics

    Bio-IT World | Modern genomics and precision medicine are generating data at a scale that is challenging traditional bioinformatics workflows. As researchers increasingly combine genomic data with phenotype, transcriptomics, proteomics, and imaging, they face growing demands for reproducible pipelines, standardized methods, and collaboration across laboratories, hospitals, and biobanks. In the latest episode of Trends from the Trenches, Ben Busby, global alliance manager for omics at NVIDIA, argues that addressing those challenges requires a shift in how scientists approach computational research.

    Sep 1, 2026

  • What Scientists Actually Need From AI

    Bio-IT World | A target looks good on paper. The literature supports it, the mechanism is plausible, and three independent groups have published findings that point the same direction. There is also a contradictory result, which someone found early, mentioned in a meeting, and set aside because it seemed less persuasive than the rest. The team builds its case, and the program advances. Years later, in preclinical validation or, worse, in the clinic, that discarded finding turns out to have been the important one.

    Aug 28, 2026

  • Follow the Money: Biological Foundation Models, Automated Bioanalysis, Predictive Cancer Care

    Bio-IT World | LifeMine Therapeutics advances a novel treatment for organ transplantation; InduPro doses the first patient in a phase 1 study of a bispecific antibody-drug conjugate; Remepy advances an AI-enabled treatment for Parkinson’s disease; and more.

    Aug 26, 2026

  • New CRISPR Screening Service, Calla Lily Joins Wellcome Leap’s Program, Baylor College to Establish Xenoliver Transplant Center

    Bio-IT World | Northwest Biotherapeutics enters a non-binding Memorandum of Understanding with the Saudi Pharmaceutical Industries and Medical Appliance Company; Novogene Europe expands its single-cell RNA sequencing capability at its Cambridge Omics Centre; and more.

    Aug 25, 2026

  • Psychedelics Reveal Immune Signatures Linked to Rapid Depression Relief

    Bio-IT World | Psychedelic drugs, such as psilocybin and ketamine, could offer a faster, more biologically targeted approach to treating depression in people with cancer, while emerging research suggests immune-system biomarkers may help identify which patients are most likely to respond. Researchers from The University of Texas MD Anderson Cancer Center are investigating how the brain and immune system interact in cancer-associated depression.

    Aug 20, 2026

  • Multiomics Study Connects Clinical Phenotypes to Molecular Signatures in Down Syndrome

    Bio-IT World | A comprehensive multiomics analysis is shedding new light on why people with Down syndrome experience vastly different health outcomes, offering evidence that molecular profiling could lay the foundation for a more personalized approach to managing the genetic condition.

    Aug 19, 2026

  • Quality Leaders Warn Against Digitizing Broken Processes

    Bio-IT World | At last week's Bioprocessing Summit, Gilead Sciences' Senior Vice President of Global Quality Anthony Mire-Sluis opened the Wednesday plenary session with a blunt warning to an industry rushing toward AI: digitizing a bad process just gets you a bad process, faster and more expensive to fix.

    Aug 18, 2026

  • The End of the ‘One-Size-Fits-All’ Parkinson’s Diagnosis: Why 2026 Is the Year Neurology Goes High-Resolution

    Bio-IT World | For over 200 years, neurology has relied on James Parkinson’s 1817 clinical observations as the definitive anchor for understanding Parkinson’s disease. Resting tremor, stooped posture, and a shuffling gait have long served as the standard diagnostic triad. Yet, Parkinson’s is far from a monolithic motor disease.

    Aug 14, 2026

  • Human Longevity Launches $600 Whole Genome

    Bio-IT World | Human Longevity last week announced the availability of Genomics for All, a clinical-grade whole genome sequencing product priced at $599. Genomics for All sequences the entire genome at 30x clinical-grade depth and is capable of identifying inherited disease risk across more than 10,000 genetic variants.

    Aug 13, 2026

  • AI-engineered Vaccine Approach Could End Cycle of Variant Chasing

    Bio-IT World | A spin-out company of the University of Cambridge is developing a pipeline technology to serve as the computer chip for a whole new class of vaccines covering a family or group of viruses targeted at different stages of their lifecycle. DIOSynVax, short for Digital Immune-Optimized Synthetic vaccines, brings together genomics, synthetic biology, artificial intelligence (AI), and immunology to design broadly protective vaccine antigens that are compatible with most vaccine delivery systems.

    Aug 12, 2026

  • A Brain Orchestra … Playing at a Range of Unsynchronized Tempos

    Bio-IT World | How does the human brain process information at different speeds, coordinate these different frames of reference, and not lose its way? Researchers at the Beckman Institute for Advanced Science and Technology at the University of Illinois Urbana-Champaign, along with several collaborators, sought to answer these questions by concurrently studying resting-state brain signaling and connectivity dynamics across a range of timescales using functional magnetic resonance imaging and source-localized electro-encephalography.

    Aug 11, 2026

  • New CEO for PacBio, Updated Chemistry for Vega System

    Bio-IT World | PacBio made several announcements this week: Mark Van Oene is the new President and CEO for the company and new chemistry and software are available for its Vega systems. Both changes aim to position the company for wider platform adoption across labs and research areas.

    Aug 7, 2026

  • ‘Reproductive Resilience Hypothesis’ Highlights the Ovary as a Discovery Source in Longevity Research

    Bio-IT World | In research published today, scientists at the Buck Institute for Research on Aging have used inductive reasoning to come up with a “Reproductive Resilience Hypothesis” suggesting that the ovary serves as the central biological hub helping to coordinate overall health. The proposal has implications for women before and after menopause, as well as men, who stand to benefit from what might be learned about the mechanisms controlling beneficial ovarian communication.

    Aug 6, 2026